Evidence map›Paper›PMID 33339089›Full record

ReviewMicroorganisms2020

Inteins in Science: Evolution to Application.

Ananya Nanda, Sourya Subhra Nasker, Ashwaria Mehra, Sunita Panda, Sasmita Nayak

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Calcimycin InhibitsACS infectious diseases · 2022
    Article
  9. Article
  10. KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Inteins as Drug Targets and Therapeutic Tools.Frontiers in molecular biosciences · 2022
    Review
  13. Article
  14. Protein Splicing of Inteins: A Powerful Tool in Synthetic Biology.Frontiers in bioengineering and biotechnology · 2022
    Review
  15. Article
  16. Article
  17. Gold Nanoparticles Augment N-Terminal Cleavage and Splicing Reactions inFrontiers in bioengineering and biotechnology · 2021
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ananya NandaSchool of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar 754021, Odisha, India.ORCID 0000-0002-9266-2698
Sourya Subhra NaskerSchool of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar 754021, Odisha, India.
Ashwaria MehraSchool of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar 754021, Odisha, India.
Sunita PandaSchool of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar 754021, Odisha, India.
Sasmita NayakSchool of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar 754021, Odisha, India.
KIIT University · IN

Funding

INSPIRE Division, DST, Government of India 201500000557/IF 140155UGC-DAE consortium for scientific research, India UGC-DAE-CSR-KC/CRS/15/IOP/08/0562
6 · The paper itself

Abstract

Inteins are mobile genetic elements that apply standard enzymatic strategies to excise themselves post-translationally from the precursor protein via protein splicing. Since their discovery in the 1990s, recent advances in intein technology allow for them to be implemented as a modern biotechnological contrivance. Radical improvement in the structure and catalytic framework of

Indexed as

applicationevolutioninteinsprotein engineeringsplicing

Identifiers

PMID33339089
PMCPMC7765530
OpenAlexW3110980423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.